Use of incretin agents and risk of pancreatic cancer: a population-based cohort study
出版年份 2016 全文链接
标题
Use of incretin agents and risk of pancreatic cancer: a population-based cohort study
作者
关键词
-
出版物
DIABETES OBESITY & METABOLISM
Volume 18, Issue 3, Pages 258-265
出版商
Wiley
发表日期
2015-11-05
DOI
10.1111/dom.12605
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Az endoszkópos retrográd cholangiopancreatographiát követő heveny hasnyálmirigy-gyulladás megelőzése
- (2015) Árpád Patai et al. ORVOSI HETILAP
- Gallstones, Cholecystectomy, and Risk of Digestive System Cancers
- (2014) Leticia Nogueira et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Use of dipeptidyl peptidase-4 inhibitors for type 2 diabetes mellitus and risk of fracture
- (2014) Johanna H.M. Driessen et al. BONE
- Dipeptidyl-peptidase-4 inhibitors and pancreatic cancer: a cohort study
- (2014) M. Gokhale et al. DIABETES OBESITY & METABOLISM
- The potential risks of pancreatitis and pancreatic cancer with GLP-1-based therapies are far outweighed by the proven and potential (cardiovascular) benefits
- (2014) R. E. J. Ryder DIABETIC MEDICINE
- Detection bias may be the main cause of increased cancer incidence among diabetics: Results from the Rotterdam Study
- (2014) Kirstin M.J. De Bruijn et al. EUROPEAN JOURNAL OF CANCER
- The incidence of acute pancreatitis: impact of social deprivation, alcohol consumption, seasonal and demographic factors
- (2013) S. E. Roberts et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Anti-Diabetic Medications and Risk of Pancreatic Cancer in Patients With Diabetes Mellitus: A Systematic Review and Meta-Analysis
- (2013) Siddharth Singh et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Marked Expansion of Exocrine and Endocrine Pancreas With Incretin Therapy in Humans With Increased Exocrine Pancreas Dysplasia and the Potential for Glucagon-Producing Neuroendocrine Tumors
- (2013) A. E. Butler et al. DIABETES
- A Critical Analysis of the Clinical Use of Incretin-Based Therapies: Are the GLP-1 therapies safe?
- (2013) P. C. Butler et al. DIABETES CARE
- Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes
- (2013) William B. White et al. NEW ENGLAND JOURNAL OF MEDICINE
- Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus
- (2013) Benjamin M. Scirica et al. NEW ENGLAND JOURNAL OF MEDICINE
- Patterns of Risk of Cancer in Patients with Metal-on-Metal Hip Replacements versus Other Bearing Surface Types: A Record Linkage Study between a Prospective Joint Registry and General Practice Electronic Health Records in England
- (2013) Arief Lalmohamed et al. PLoS One
- Alcohol consumption on pancreatic diseases
- (2013) Marta Herreros-Villanueva WORLD JOURNAL OF GASTROENTEROLOGY
- Pressure mounts for companies to hand over data on antidiabetes drugs linked to pancreatic harm
- (2013) D. Cohen BMJ-British Medical Journal
- Incretins and risk of neoplasia
- (2013) T. R. Halfdanarson et al. BMJ-British Medical Journal
- Glucagonlike Peptide 1–Based Therapies and Risk of Hospitalization for Acute Pancreatitis in Type 2 Diabetes Mellitus
- (2013) Sonal Singh et al. JAMA Internal Medicine
- Safety and Tolerability of Sitagliptin in Type 2 Diabetes: Pooled Analysis of 25 Clinical Studies
- (2013) Samuel S. Engel et al. Diabetes Therapy
- Use of Antidiabetic Agents and the Risk of Pancreatic Cancer: A Case–Control Analysis
- (2012) Michael Bodmer et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Chronic GLP-1 Receptor Activation by Exendin-4 Induces Expansion of Pancreatic Duct Glands in Rats and Accelerates Formation of Dysplastic Lesions and Chronic Pancreatitis in the KrasG12DMouse Model
- (2012) Belinda Gier et al. DIABETES
- Exenatide-Induced Chronic Damage of Pancreatic Tissue in Rats
- (2012) Xiao Yu et al. PANCREAS
- The association of pancreatitis with antidiabetic drug use: gaining insight through the FDA pharmacovigilance database
- (2011) E. Raschi et al. ACTA DIABETOLOGICA
- Diabetes mellitus and risk of pancreatic cancer: A meta-analysis of cohort studies
- (2011) Qiwen Ben et al. EUROPEAN JOURNAL OF CANCER
- Pancreatitis, Pancreatic, and Thyroid Cancer With Glucagon-Like Peptide-1–Based Therapies
- (2011) Michael Elashoff et al. GASTROENTEROLOGY
- GLP-1–Based Therapies: The Dilemma of Uncertainty
- (2011) Joachim Spranger et al. GASTROENTEROLOGY
- Incretin-Based Therapies for the Treatment of Type 2 Diabetes: Evaluation of the Risks and Benefits
- (2010) D. J. Drucker et al. DIABETES CARE
- Incidence, Severity, and Etiology of Drug-Induced Acute Pancreatitis
- (2010) Ilona Vinklerová et al. DIGESTIVE DISEASES AND SCIENCES
- Distant metastasis occurs late during the genetic evolution of pancreatic cancer
- (2010) Shinichi Yachida et al. NATURE
- Glucagon-like peptide analogues for type 2 diabetes mellitus: systematic review and meta-analysis
- (2010) Deepson S Shyangdan et al. BMC Endocrine Disorders
- Validation and validity of diagnoses in the General Practice Research Database: a systematic review
- (2009) Emily Herrett et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Biochemical and histological effects of exendin-4 (exenatide) on the rat pancreas
- (2009) J. S. Nachnani et al. DIABETOLOGIA
- Patterns and trends of pancreatic cancer mortality rates in Arkansas, 1969–2002: a comparison with the US population
- (2009) Jianjun Zhang et al. EUROPEAN JOURNAL OF CANCER PREVENTION
- Fracture risk in patients receiving acid-suppressant medication alone and in combination with bisphosphonates
- (2009) F. de Vries et al. OSTEOPOROSIS INTERNATIONAL
- GLP-1 receptor signaling: effects on pancreatic β-cell proliferation and survival
- (2008) J. Buteau DIABETES & METABOLISM
- Prevalence and Clinical Profile of Pancreatic Cancer–Associated Diabetes Mellitus
- (2008) Rahul Pannala et al. GASTROENTEROLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started